Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/29/2025

Indications for Bentall Surgery in Marfan Syndrome

Primary Size-Based Indications

  • The American College of Cardiology recommends that patients with Marfan syndrome undergo Bentall procedure when aortic root diameter reaches ≥5.0 cm, or earlier at ≥4.5 cm when additional risk factors are present, particularly when significant aortic regurgitation coexists or valve-sparing surgery is not feasible 1, 2, 3
  • The fundamental threshold for aortic root surgery in Marfan syndrome is an external aortic diameter of ≥5.0 cm, which is lower than the 5.5 cm threshold used for non-syndromic patients due to the increased propensity for dissection at smaller diameters 4, 5

Indications for Earlier Surgery (<5.0 cm)

  • Surgery should be performed at diameters <5.0 cm when rapid aortic growth ≥0.3-0.5 cm/year on serial imaging with side-by-side comparison is present 4, 3, 6
  • The American Heart Association suggests that patients with Marfan syndrome and a family history of aortic dissection, especially if dissection occurred at diameters <5.0 cm, should undergo surgery at diameters <5.0 cm 4, 3, 6
  • Patients with severe (3-4+) aortic regurgitation requiring intervention should undergo surgery at diameters <5.0 cm 4, 5, 6
  • Women with Marfan syndrome who desire pregnancy and have an aortic diameter >4.0 cm should undergo surgery before conception 4, 5, 7, 6

Bentall vs. Valve-Sparing Procedures: Decision Algorithm

  • The Bentall procedure is preferred when significant aortic valve pathology exists with moderate-to-severe (3-4+) aortic regurgitation that cannot be repaired, or when aortic valve cusps are structurally abnormal and unsuitable for preservation 2, 3
  • The Valve-Sparing (David) procedure should be considered when aortic valve cusps are structurally normal with minimal or no regurgitation, or when surgery is elective and performed by experienced surgeons in a Multidisciplinary Aortic Team 1, 2, 3

Clinical Outcomes and Considerations

  • The Valve-Sparing procedure avoids anticoagulation but carries a 6-7% risk of developing moderate AR requiring reoperation 1

Special Populations

  • Pregnant patients with Marfan syndrome and an aortic diameter >4.0 cm before conception should undergo prophylactic surgery prior to pregnancy 4, 5, 7, 6
  • Frequent cardiovascular monitoring throughout pregnancy and puerperium is mandatory for all Marfan women 4, 5

Critical Pitfalls to Avoid

  • Delaying surgery until 5.5 cm, as used in non-Marfan patients, is not recommended; dissection risk increases substantially above 5.0 cm 4, 1, 6
  • Using internal diameter measurements alone is not recommended; guidelines reference external diameters, and internal measurements underestimate true size 4
  • Assuming medical therapy eliminates surgical need is incorrect; beta-blockers and ARBs slow but do not prevent aortic growth 4, 5
  • Forgetting lifelong surveillance of remaining aortic segments post-operatively is a critical pitfall, as arch and descending aorta remain at risk 4, 5

REFERENCES

6

Risk Features for Aortic Dissection in Marfan Syndrome [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025